Confirmed: AstraZeneca Experimental COVID Injection Causes Fatal Blood Clots – Trials with Children Halted
Just days after Australia's deputy chief medical officer, Michael Kidd, acknowledged that there was likely a connection between rare blood clots and the COVID vaccine developed by AstraZeneca and Oxford, officials from the EMA, Europe's top pharmaceutical regulator, have finally acknowledged the link, even if the agency's official stance - that there's no evidence of a link, but no evidence to rule it out - remains unchanged. The EMA declared at the conclusion of a hasty "safety review" last month that the benefits of the AstraZeneca jab (which is expected to to be the workhorse of the global vaccination rollout as Covax, the WHO/Gates Foundation program to vaccination developing countries, expects to heavily rely on the jab) far outweighed any risks, while saying it couldn't definitively rule out the possibility that the blood clots and the vaccine might be connected. But researchers from Norway, Germany and elsewhere insisted they had found evidence of a connection. And after the UK acknowledged more than 2 dozen new cases of the rare clots - 9 of them fatal - it seems the dam has finally broken. WSJ reported Tuesday that the University of Oxford had decided to pause trials of the vaccine in the UK that involved children between the ages of 12 and 15.